Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV000195250 | SCV002012136 | pathogenic | Autosomal dominant Robinow syndrome 2 | 2021-10-02 | criteria provided, single submitter | clinical testing | Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). The variant has been reported as pathogenic/likely pathogenic without evidence for the classification (ClinVar ID: VCV000504195.6). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Gene |
RCV003223617 | SCV003919668 | pathogenic | not provided | 2023-04-20 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation, as the last 164 amino acids are replaced with 141 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging gain of function effect (Bunn et al., 2015); This variant is associated with the following publications: (PMID: 30266093, 25817016, 25817014, 32888393, 33237614, 35047859) |
Labcorp Genetics |
RCV003223617 | SCV005833820 | pathogenic | not provided | 2025-01-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp507Glyfs*142) in the DVL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 164 amino acid(s) of the DVL1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Robinow syndrome (PMID: 25817014, 25817016, 35047859). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 208045). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000195250 | SCV000222663 | pathogenic | Autosomal dominant Robinow syndrome 2 | 2015-04-02 | no assertion criteria provided | literature only | |
Gene |
RCV000195250 | SCV000243849 | not provided | Autosomal dominant Robinow syndrome 2 | no assertion provided | literature only | ||
Lupski Lab, |
RCV000195250 | SCV000256688 | pathogenic | Autosomal dominant Robinow syndrome 2 | 2020-09-30 | no assertion criteria provided | research |